Tag: 上海419龙凤网莞式

School board confirms COVID-19 case at Worsley Elementary in Wasaga Beach

For the second time in as many days, a COVID-19 case has been confirmed at a school in South Georgian Bay.

The Simcoe County District School board confirmed a case at Worsley Elementary School in Wasaga Beach.

The board sent home letters to parents but would not confirm if it was a teacher or student who tested positive.

A classroom is closed at the school.

This follows a confirmed case at Admiral Collingwood Elementary School on Monday, which also resulted in a classroom being closed.

Corrine Lalonde has two children at the school and said the necessary steps are being taken.

“I think the school and public health are doing what needs to be done and as long as kids and teachers are following the guidelines at the school, the risk is very low,” she said. “Each parent can make a decision as to what is right for their family and child.”

Rapid at-home COVID testing remains a dream for Canadians

The dream of at-home rapid testing for COVID-19 in Canada remains just that: a dream.

Health Canada has not received any applications for at-home testing kits, though says it has proactively reached out to manufacturers of such tests and encouraged them to apply.

The FDA granted emergency authorization last week to the first home-based rapid test in the United States, but the company behind it — which was approached by Health Canada — says it has no plans for now to expand into Canada.

Some health experts — as well as opposition politicians — have said what Canada needs is inexpensive and rapid home-based testing, which could lessen the need for long testing lineups and lockdowns.

“I believe that Canada would have the capacity to make home tests if the government pointed its focus that way in regards to funding them,” said Dr. Funmi Okunola, president of Kojala Medical Enterprises Ltd, and a Vancouver-based family physician and COVID-19 medical adviser.

Okunola advocates for the development and use of inexpensive, rapid paper-based COVID-19 tests similar to pregnancy tests, but instead of urine they would use mucus or saliva.

And she says the federal government should be directing more funding at their development, similar to what they’ve done with vaccine research, to scale up production and ultimately bring down costs for individuals.

“Providing there was a comprehensive strategy implemented alongside these home tests and proper education, then if they were used, really in my opinion they would turn the tide of the pandemic, and would buy us time and reduce the spread of COVID-19 while we’re waiting for the vaccines,” she said.

Such tests have been the focus of research both in the United States and in Canada, including work being conducted by Professor Alexandre Brolo in the department of chemistry at the University of Victoria.

“We are working on it,” Brolo said. “It’s a team of very talented researchers. I sometimes look at the news and people are saying ‘We need more tests.’ We are trying. It’s not easy, but I think that we have some encouraging results and I’m hoping that we will be able to contribute to the pandemic at some point.”

In the meantime, a first-of-its kind home-based COVID-19 detection test was given emergency-use authorization from the U.S. Food and Drug Administration last week.

The Lucira All-in-One Test Kit allows individuals to collect their own swab, place it in the test unit (which is a single-use device) and learn the results in under 30 minutes.

According to a company news release, a trial involving more than 100 individuals which compared Lucira results with one of the FDA’s high-sensitivity tests showed positive results agreed 94.1 per cent of the time across all samples, and 98 per cent of the time for negative results.

The test is only authorized to be used by individuals with a prescription, and for now will only be made available in some health-care settings on a limited basis to prescribe to patients for use at home. The company said in a news release that it plans to scale up production so that the kits — which retail about $50 (U.S.) — would be available nationally by spring 2021.

A company spokesperson said they have no plans for now to expand into Canada.

“We have been singularly focused on the FDA, because that’s the foundation for being able to go out there and start manufacturing,” said spokesperson Kevin Knight. “We’re focused on lining up production right now.”

A handful of other firms in the U.S. have been given emergency authorization since the spring to sell home-based collection kits, which allow individuals to take their own nasal or saliva samples but still requires them to send it to a lab for results.

No such home-based collection kits are currently authorized in Canada, and Okunola said it would require already-backlogged labs to ramp up capacity even more to process the results.

At least two American firms with emergency authorization to sell saliva-based home collection devices — Spectrum Solution and P23 Labs — told the Star they also applied to Health Canada months ago, but have yet to get a final decision.

P23 Labs, which received emergency authorization from the FDA in May for its saliva-based home-collection kit, said it was approached by Health Canada in August to submit an application, and the company did so in September.

The company said the process to apply to Health Canada is not as clearly defined as the process for applying to the FDA.

“Nothing from the FDA carries over. The paper trail and documentation required is more difficult. We are stuck as they will not accept the letters of reference from our manufacturers of some of the kit components,” the company said in a statement to the Star.

“P23 Labs is eager to make our at-home COVID19 test kit available and accessible to Canadian customers, as a means to make testing easier and more convenient, and to lessen potential exposure to and spread of the virus.”

Spectrum Solution said it began the process with Health Canada in June. The company said it found the FDA’s and Health Canada’s processes to be “very similar,” though they said unlike Health Canada, the FDA provided a clear estimation of the time the process would take.

Health Canada told the Star it is “working closely” with manufacturers, including P23 Labs and Spectrum Solution, “to determine whether their devices meet safety and effectiveness requirements.”

The regulator said it has received multiple “interim order” applications for several types of saliva collection kits, including some that are home-based. It said it has yet to receive applications for devices that combine saliva collection with COVID-19 testing at home.

(Interim order applications mean that “products that may not fully meet Canadian regulatory requirements but are manufactured to comparable standards may be imported,” according to Health Canada’s website.)

The opposition Conservatives have been adamant that rapid and at-home testing capabilities must be scaled up in Canada to respond to the COVID-19 pandemic, something they’ve accused the federal government of dropping the ball on.

“What we need…is widespread access to frequent, rapid and at-home tests so that we can have targeted isolation measures that more effectively prevent the spread of COVID-19 rather than simply asking Canadians to sit at home for months and months on end without any hope or clarity of how this is going to come to an end,” Conservative health critic Michelle Rempel Garner told reporters this week.

Physician epidemiologist Dr. Nitin Mohan said in an at-home testing scenario, there could be concerns with the test’s sensitivity or whether the individual has properly collected their sample.

He said such concerns could be tempered if a screening tool was included as well. For example, ETIO Public Health Consultants, of which Mohan is partner, recently joined forces with Ontario-based firm Virocule to help launch a testing device that detects loss of smell, a common COVID-19 symptom. The device received Health Canada authorization last month.

He said a screening protocol could include not just the smell testing device, but also whether the person has a fever or other COVID-19 symptoms, prior to taking the actual test for the virus.

“It diminishes the risk of a false negative (test),” said Mohan. “We’re not eliminating it, but we’re dropping that risk down by the time you actually get the test done.”

Jacques Gallant is a Toronto-based reporter for the Star. Follow him on Twitter:

Depression, anxiety, dementia. Studies link COVID-19 to a number of mental health disorders

Jan Willis found herself in Puerto Vallarta when was declared a worldwide pandemic in March. Before she could return to her native British Columbia, the 66-year-old was met with a flurry of cruise passengers, most of them sick with the virus.

“I’m fairly certain that’s where I caught it,” Willis said.

When she returned to her hometown of Victoria, her doctor told her to self-isolate immediately. Early on in the pandemic, there was no widespread testing and Willis was declared a presumptive case of COVID-19.

Alongside physical symptoms, including lung issues, body pains and diarrhea, Willis also experienced psychiatric symptoms. The most severe, she said, was a hallucination she had of a cloud hanging above her a few weeks after her diagnosis, which then proceeded to enter her, causing a wave of sadness.

“It was this absolutely profound depression that I’ve never experienced before,” Willis said.

The sadness persisted, she said, and her mood continued to fluctuate even after she was declared free of the virus, prompting her doctor to prescribe antidepressants. Nine months later, she continues to be on the medication.

Research shows Willis is not alone in experiencing depression symptoms after contracting COVID-19. A University of Oxford study, in November, revealed nearly one in five COVID-19 patients in the United States were diagnosed with a psychiatric disorder within 14 to 90 days of their COVID-19 diagnosis — many of whom had no history of mental illness.

The data was obtained by examining the health records of 69 million patients in the U.S., 62,300 of whom had a COVID-19 diagnosis. Similar research has not been completed yet in Canada, but studies out of and reveal the same outcome: COVID-19 survivors have a higher chance of developing mental disorders in early stages of recovery.

Researchers are left pondering, then, whether this is a result of trauma from contracting COVID-19, or is due to the virus’ ability to enter and alter the brain’s functions. This has prompted calls for longer-term studies on the topic. But Willis maintains her symptoms are more than virus fatigue.

“I could feel the difference between what we’re all experiencing in terms of the pandemic, versus the biological [depression] that was happening to me that was out of control,” Willis said.

It’s not beyond the realm of possibilities that COVID-19 could cause an array of psychiatric disorders, as there is a precedent of viruses causing neurological symptoms, said Roger McIntyre, a professor of psychiatry and pharmacology at the University of Toronto.

But McIntyre added it’s still not clear why patients are experiencing this outcome, although there are a few possible theories.

“The virus itself may be directly toxic to the brain,” McIntyre said, adding the loss of taste and smell, a common COVID-19 symptom, suggests the virus can penetrate the brain. Another theory, he said, is the cytokine storm — caused by the body’s immune system going on overdrive in an attempt to fight the virus — can actually alter the brain’s functions.

“Too much of the bad guy cytokines can actually cause mental illness,” McIntyre said. “They attack your brain.”

Treatments for COVID-19 could also be a factor, he added. Steroids, which have been used to treat many COVID-19 patients, may inadvertently cause mental illness, McIntyre said.

The possibility of COVID-19 being directly related to psychiatric disorders only adds to the swirl of uncertainty surrounding the virus, and few concrete answers are available on whether the trauma of experiencing the virus in the first place is also contributing to mental health concerns.

Jane Cotman, a 58-year-old Mississauga woman, contracted the virus in March. But for her, the mental health symptoms seem to be more tied to the fatigue of having lingering physical symptoms of the virus itself.

“My mental health suffers at times when I can’t pinpoint my pain or fatigue or shortness of breath,” Cotman said. “It’s a constant reminder that I am not yet back to being me.”

Nine months later, Cotman continues to suffer from brain fog, extreme fatigue and insomnia with no answers as to why, despite being extremely healthy and active prior to falling ill with COVID-19, adding to her sense of worry and frustration.

The symptoms highlighted in the University of Oxford research are different from the frequently documented “long hauler” COVID-19 symptoms of fatigue and brain fog, and are rather symptoms of depression, anxiety, dementia and post-traumatic stress disorder, McIntyre noted.

But whatever the reason behind these symptoms might be, “it’s something that we now need to pay attention to,” McIntyre said.

With so much uncertainty continuing to swirl around the virus and its effects, the psychiatric symptoms are an issue Willis said she would like doctors to especially be aware of.

“We need to be listened to and understood,” said Willis, who is currently seeking counselling because of her experience with COVID-19. “You need that support, you need someone to say, ‘What do you need?’”

An open letter , written by doctors who were sick with COVID-19 themselves, called for a multidisciplinary response to treating recovering patients and the creation of one-stop clinics where patients can access different types of care to combat long-term symptoms of their illness.

It is an approach McIntyre echoed, adding a primary care provider and a team of specialists, which includes neurologists or psychiatrists, should be accessible to those recovering from COVID-19 as it has been proven to be a disease that affects an array of organs in the body.

McIntyre said regardless of whether the virus is directly responsible for psychiatric disorders, the pandemic has proven to be “the greatest mental health assault on the general population ever recorded in humanity,” for social, economic and health reasons.

“People are under chronic stress, and they don’t know when it’s going to end,” McIntyre said.

It is imperative, then, that COVID-19 survivors are connected to mental health help and support, he said, whether it be through community clinics, online resources like the Canadian Mental Health Association, or their primary care provider.

“A lot of people will be really perplexed because they won’t know this is all related, and they may feel even guilty for having these problems,” McIntyre said.

But depression is treatable, McIntyre added, and COVID-19 survivors should not hesitate to reach out to a clinician if they feel its symptoms.

Nadine Yousif is a Toronto-based reporter for the Star covering mental health. Her reporting is funded by the Canadian government through its Local Journalism Initiative. Follow her on Twitter: